SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):67P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, K.
Right arrow Articles by Chen, X.
PubMed
Right arrow Articles by Chen, K.
Right arrow Articles by Chen, X.

Novel Approaches to Molecular Imaging

Optical and Bioluminescence

Quantum dot based dual functional probe for optical/PET imaging of tumor VEGFR

Kai Chen1, Zi-bo Li1, Hui Wang1, Weibo Cai1 and Xiaoyuan Chen1

1 Stanford U, Stanford, California


Formula


Formula

266

Objectives: To date, the in vivo imaging of quantum dots (QDs) has been mostly qualitative or semiquantitative. It is needed to develop a dual-function PET/near-infrared fluorescence (NIRF) probe for accurate assessment of tumor-targeting efficacy of QDs.

Methods: QD705 surface was conjugated with DOTA chelator for 64Cu-labeling and PET imaging, and with VEGF121 protein for VEGFR-2 targeting in a subcutaneous U87MG tumor model. The efficiency of this optical/PET dual functional probe was evaluated in vitro, in vivo, and ex vivo.

Results: DOTA-QD-VEGF121 binds VEGFR-2 with high affinity and specificity based on competitive cell binding assay and fluorescence cell staining. Both NIRF and PET imaging of 64Cu-DOTA-QD705-VEGF121 demonstrated quick tumor contrast and increased tumor signal with time, however, optical imaging is qualitative while PET imaging is quantitative. Prominent RES uptake (liver, spleen and lymph nodes) was also observed. 64Cu-DOTA-QD705 on the other hand did not show any visible tumor uptake throughout the experiment. Ex vivo PET and NIRF imaging were also carried out to further confirm the in vivo imaging results in major organs. Immunofluorescence staining of VEGFR2 on frozen U87MG tumor section confirmed that 64Cu-DOTA-QD705-VEGF121 specifically targets the tumor vasculature through VEGF/VEGFR-2 binding and only a very small fraction of QD may extravasate.

Conclusions: This is the first study to use QD-based NIRF imaging and PET imaging to specifically target tumor vascular VEGFR-2 and quantitatively evaluate the targeting efficacy.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, K.
Right arrow Articles by Chen, X.
PubMed
Right arrow Articles by Chen, K.
Right arrow Articles by Chen, X.